Public Inspection: HHS: Eighth Amendment to Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID –19
Notice of amendment from the Department of Health and Human Services to expand the authority for certain qualified pharmacy technicians to prescribe, dispense, and administer childhood vaccinations and COVID-19 vaccinations. Also expands the authorization for qualified pharmacy technicians and interns to administer seasonal influenza vaccines under the supervision of a pharmacist to people age 19 and older. This amendment will be effective upon official publication in the Federal Register, which is scheduled for August 4, 2021. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - August 3, 2021 Category: Rural Health Source Type: news
General practice enhanced service specifications for flu jabs
NHS England has published two enhanced service specifications for the seasonal influenza vaccination programme 2021/22. (Source: NHS Networks)
Source: NHS Networks - August 3, 2021 Category: UK Health Source Type: news
Community-acquired bacterial meningitis
Progress has been made in the prevention and treatment of community-acquired bacterial meningitis during the past three decades but the burden of the disease remains high globally. Conjugate vaccines against the three most common causative pathogens (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae) have reduced the incidence of disease, but with the replacement by non-vaccine pneumococcal serotypes and the emergence of bacterial strains with reduced susceptibility to antimicrobial treatment, meningitis continues to pose a major health challenge worldwide. In patients presenting with bacterial m...
Source: Current Awareness Service for Health (CASH) - July 28, 2021 Category: Consumer Health News Source Type: news
The 6 Factors That Will Determine the Severity of the COVID-19 Surge in the U.S. This Fall
Here we go again. The United States is now experiencing a fourth wave of COVID-19, with very rapidly rising infections. The surge in new daily cases is driven by the Delta variant, which makes up 83% of sequenced samples in the U.S. and which is estimated to be twice as transmissible as the original strain. One of the reasons that Delta spreads more easily is that a person infected with this variant has a viral load 1,000 times higher than someone infected with the original version of SARS-CoV-2. [time-brightcove not-tgx=”true”] Hospitalizations and deaths are also rising, though more slowly than cases, reflect...
Source: TIME: Health - July 26, 2021 Category: Consumer Health News Authors: Gavin Yamey and Nahid Bhadelia Tags: Uncategorized COVID-19 Source Type: news
GlaxoSmithKline begins shipping a record quantity of influenza vaccine doses for flu season
GlaxoSmithKline has started shipping what it said will be a record number of its quadrivalent influenza vaccine doses to U.S. health care providers and pharmacies for the 2021-22 flu season. GSK (NYSE: GSK) expects to distribute more than 50 million doses of its influenza vaccine for the upcoming flu season. The shipping follows a licensing and lot-release approval for the vaccine from the Food and Drug Administration's Center for Biologics Evaluation and Research. The Centers for Di sease Control… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 26, 2021 Category: American Health Authors: John George Source Type: news
Anxiety-Related Adverse Events After Janssen COVID-19 Vaccine Anxiety-Related Adverse Events After Janssen COVID-19 Vaccine
Syncope and other anxiety-related events occur more often after receipt of Janssen COVID-19 vaccination compared to the influenza vaccination, according to this CDC report.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
Why the Respiratory Disease RSV Is Having an Off-Season Surge
Dr. James Antoon, an assistant professor of pediatrics at Vanderbilt University Medical Center, often goes an entire summer without diagnosing a single case of respiratory syncytial virus (RSV). The common illness, which typically results in mild, cold-like symptoms but can be severe in infants and elderly adults, usually goes along with the winter flu season. But this summer, RSV cases are spiking, particularly in southern states. Around 2,000 confirmed cases were recorded across the U.S. during the week of July 10, 2021, compared to less than a dozen during the week of July 25, 2020. The actual number of infections is li...
Source: TIME: Health - July 22, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Source Type: news
COVID-19 Caused U.S. Life Expectancy to Drop 1.5 Years
Life expectancy in the United States dropped the most in more than seven decades last year as Covid-19 sent hundreds of thousands of Americans to early deaths. The pandemic’s disproportionate toll on communities of color also widened existing gaps in life expectancy between White and Black Americans, according to estimates released by the Centers for Disease Control and Prevention. The tally represents an extraordinarily grim accounting of an ongoing catastrophe. The first year of the pandemic delivered a bigger blow to American life expectancy than any year of the Vietnam War, the AIDS crisis or the “deaths of...
Source: TIME: Health - July 21, 2021 Category: Consumer Health News Authors: John Tozzi / Bloomberg Tags: Uncategorized COVID-19 overnight wire Source Type: news
Afluria Quadrivalent 2020 (2020 Influenza Vaccine Suspension for Intramuscular Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 21, 2021 Category: Drugs & Pharmacology Source Type: news
Of lives and life years: 1918 influenza vs COVID-19
(Society for Disaster Medicine and Public Health, Inc.) We must not assume that we will be able to replicate a vaccine within 12 months during the next pandemic. Even if this was accomplished, other interventions would be required to control and mitigate well before the availability of a vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 19, 2021 Category: International Medicine & Public Health Source Type: news
Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey, BMJ Open
This cross-sectional survey (n=570) found 59.7% were likely to have the vaccination, 22.1% unlikely& 18.2% were unsure. Logistic regression results suggested individuals who had the vaccine last season were likely to intend to have it again in the 2020 –2021 season. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 15, 2021 Category: Consumer Health News Source Type: news
The FDA ’s New Guillain-Barre Warning For the J & J Vaccine Reflects a Small Increased Risk of the Illness
As millions of people get vaccinated against COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are closely monitoring reports of side effects and adverse events among people getting immunized. On July 12, the FDA added a warning about the risk of Guillain-Barre to the single-dose Janssen/Johnson & Johnson vaccine. Anyone who receives the shot moving forward will get an updated fact sheet informing them of the small but increased risk. There have not been significant reports of the syndrome linked to the two other vaccines authorized in the U.S., made by Pfize...
Source: TIME: Health - July 13, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Flu jab may reduce severe effects of Covid, suggests study
Analysis of 75,000 coronavirus patients found fewer major health problems among people with flu jabCoronavirus – latest updatesSee all our coronavirus coveragePeople who are vaccinated against influenza may be partly protected against some of the severe effects of coronavirus, and be less likely to need emergency care, according to a major study.The analysis of nearly 75,000 Covid patients found significant reductions in stroke, deep vein thrombosis (DVT) and sepsis, and fewer admissions to emergency departments and intensive care units, among those who had been given the flu jab.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 12, 2021 Category: Science Authors: Ian Sample Science editor Tags: Medical research Coronavirus Vaccines and immunisation Health UK news Source Type: news
COVID-19 News from Annals of Internal Medicine
(American College of Physicians) Authors from Brigham and Women's Hospital and Harvard Medical school say the case for mandating SARS-CoV-2 vaccination among health care workers is substantially stronger than the case for mandating influenza vaccination, which has become widely accepted. The authors detail the many reasons for mandatory vaccination and strategies for gaining employee acceptance in a commentary published in Annals of Internal Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 12, 2021 Category: Infectious Diseases Source Type: news
Should People With Immune Problems Get Third Vaccine Doses?
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own. (Source: NYT Health)
Source: NYT Health - July 4, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Transplants Clinical Trials Vaccination and Immunization Research Antibodies Drugs (Pharmaceuticals) Immune System Disease Rates Coronavirus (2019-nCoV) Influenza Moderna Inc France United States Source Type: news
Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two preprint study summaries have been submitted today to bioRxiv. “Today’s newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine ...
Source: Johnson and Johnson - July 1, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Why You Still Might Want to Have a Home Covid Test on Hand
At-home rapid Covid-19 tests can offer unique benefits for weddings, parties, travel or for households with children or at-risk adults. (Source: NYT Health)
Source: NYT Health - June 29, 2021 Category: Consumer Health News Authors: Tara Parker-Pope Tags: Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Content Type: Service Vaccination and Immunization Parties (Social) Weddings and Engagements Influenza Source Type: news
Future of covid-19 vaccine pricing: lessons from influenza, BMJ
BMJ Analysis suggests that if the pattern observed with influenza vaccines is repeated, higher prices for covid-19 vaccines set by companies in the future would have important implications for health spending, public health programme budgets, and insurance premiums. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 23, 2021 Category: Consumer Health News Source Type: news
Maternal Influenza Vaccination During Pregnancy Not Tied to Adverse Early Childhood Outcomes Maternal Influenza Vaccination During Pregnancy Not Tied to Adverse Early Childhood Outcomes
Women who receive the influenza vaccination during pregnancy are no more likely than those who don't to have offspring with adverse health outcomes in early childhood, a new study suggests.Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 14, 2021 Category: Infectious Diseases Tags: Ob/Gyn & Women ' s Health News Source Type: news
A third dose of COVID-19 vaccine increased antibody levels in organ transplant recipients with a sub
(American College of Physicians) A case series published in Annals of Internal Medicine found that a third dose of vaccine increased antibody levels in organ transplant recipients who had suboptimal response to standard vaccination. These findings suggest that clinical trials are warranted to determine whether booster doses should be incorporated into clinical practice for transplant patients, just as they have been for hepatitis B and influenza vaccinations. This is the first study to report on response to a third vaccine dose. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 14, 2021 Category: Infectious Diseases Source Type: news
So when you DIE from the Covid-19 vaccine you got because they gave away free pot and cannabis in trade for it, will the CDC blame the weed?
(Natural News) Nearly every death in America during the “pandemic” was blamed on Covid-19 in order to perpetuate the threat and the narrative. If you caught influenza and died from it… Covid-19. If you caught Covid-19 and died from being suffocated by a ventilator, then you died from Covid, on paper. If you committed suicide... (Source: NaturalNews.com)
Source: NaturalNews.com - June 13, 2021 Category: Consumer Health News Source Type: news
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
You don’t want to be a virus in Dr. David Ho’s lab. Pretty much every day since the COVID-19 pandemic began, Ho and his team have done nothing but find ways to stress SARS-CoV-2, the virus that causes the disease. His goal: pressure the virus relentlessly enough that it mutates to survive, so drug developers can understand how the virus might respond to new treatments. As a virologist with decades of experience learning about another obstinate virus, HIV, Ho knows just how to apply that mutation-generating stress, whether by starving the virus, bathing it in antibodies that disrupt its ability to infect cells, ...
Source: TIME: Health - June 11, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Genetics Magazine Source Type: news
How Cochrane is responding to COVID-19 in 2021
In 2020, Cochrane ’s editorial response to COVID-19 pandemic brought together collaborations across our global organization to publish reviews addressing stakeholder needs as they emerged. Large, highly organized review teams worked together to produce evidence addressing priorities in treatment, prevention, and di agnostics. In 2021, Cochrane continues to produce new and updated reviews in response to the pandemic.In this interview with Deputy Editor in Chief Toby Lasserson and Executive Editor of Cochrane's Central Editorial Service Helen Wakeford, we ask them about Cochrane ’s editorial ap...
Source: Cochrane News and Events - June 9, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news
NIAID Advances Universal Flu Vaccine Candidate Into Phase 1 Trial NIAID Advances Universal Flu Vaccine Candidate Into Phase 1 Trial
Earlier attempts to develop a universal flu shot failed in clinical trials. But advances in immunology raise the chances for development of broad-acting vaccines against influenza, an expert says.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 7, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Teens Are Rarely Hospitalized With Covid, but Cases Can Be Severe
Adolescents were hospitalized with Covid three times as often as with flu, researchers reported. Nearly one-third wound up in I.C.U.s. (Source: NYT Health)
Source: NYT Health - June 4, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus Risks and Safety Concerns Disease Rates Coronavirus (2019-nCoV) Vaccination and Immunization Influenza Rumors and Misinformation Research Deaths (Fatalities) United States Teenagers and Adolescence Source Type: news
Lessons from the last pandemic point the way toward universal flu vaccines
(University of Chicago Medical Center) A new study from the University of Chicago and Scripps Research Institute shows that during the last great pandemic--2009's H1N1 influenza pandemic--people developed strong, effective immune responses to stable, conserved parts of the virus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news
Researcher gets $2.7 million grant to study seasonal and universal vaccination in aged populations
(Georgia State University) Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2021 Category: International Medicine & Public Health Source Type: news
Broadly neutralizing antibodies against pandemic flu point to new vaccine targets
(American Association for the Advancement of Science) A new study reveals that B cells can produce antibodies against the H1N1 influenza virus that also neutralize various other influenza strains, marking a development that could inform research into potential universal flu vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 2, 2021 Category: Infectious Diseases Source Type: news
NIH launches clinical trial of universal influenza vaccine candidate
Nanoparticle vaccine developed by NIAID scientists. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 1, 2021 Category: American Health Source Type: news
NIH launches clinical trial of universal influenza vaccine candidate
(NIH/National Institute of Allergy and Infectious Diseases) A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against multiple flu virus strains has begun. Healthy participants 18 to 50 years old will receive either a licensed seasonal influenza vaccine or the experimental vaccine, FluMos-v1. Scientists from NIAID developed FluMos-v1 to stimulate antibodies against multiple influenza virus strains by displaying part of the influenza virus hemagglutinin (HA) protein on self-assembling nanoparticle scaffolds...
Source: EurekAlert! - Infectious and Emerging Diseases - June 1, 2021 Category: Infectious Diseases Source Type: news
Geisel School of Medicine Student Arvind Suresh Receives Prestigious Public Health Service Award
Second-year medical student Arvind Suresh ’23 has been recognized for his leadership in organizing and managing student-run mobile community influenza vaccination clinics in NH and VT. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 27, 2021 Category: Hospital Management Authors: Susan Green Tags: Improving Lives News Source Type: news
When Battling Covid-19 Becomes a National Policy Disaster
The COVID-19 vaccine administered through the COVAX Facility. Credit: PAHO/Karen GonzálezBy Darini Rajasingham-SenanayakeCOLOMBO, Sri Lanka, May 19 2021 (IPS) We went to the Kanatte cemetery, Sri Lanka’s largest, where most of us, residents of the capital city, would end up sooner or later. But it was deserted, and so we had time for a leisurely chat with some of the helpful staff there, albeit after admiring some of the grave sites and remaining beautiful trees. As good social scientists and medical anthropologists, we were on a mission to do some qualitative research and cross-check Covid-19 quantitative da...
Source: IPS Inter Press Service - Health - May 19, 2021 Category: International Medicine & Public Health Authors: Darini Rajasingham-Senanayake Tags: Aid Development & Aid Editors' Choice Featured Global Headlines Health Human Rights Humanitarian Emergencies Population Poverty & SDGs TerraViva United Nations Source Type: news
ACC: Only Half of Cardiovascular Disease Patients Receive Flu Vaccine
TUESDAY, May 18, 2021 -- Only half of the U.S. population with cardiovascular disease report being up to date on influenza vaccination, according to a study presented at the annual meeting of the American College of Cardiology, held virtually from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 18, 2021 Category: Pharmaceuticals Source Type: news
Towards a universal flu vaccine for Indigenous populations
(University of Melbourne) Researchers have identified specific influenza targets that could be used to better protect Indigenous people from experiencing severe influenza disease through a universal, T cell-based vaccine.In a collaboration with Monash Biomedicine Discovery Institute, Menzies School of Health Research and CQUniversity, Peter Doherty Institute for Infection and Immunity (Doherty Institute) researchers took a deep-dive look into how the immune system can protect Aboriginal and Torres Strait Islander people from severe influenza disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 18, 2021 Category: Infectious Diseases Source Type: news
Novavax Announces positive preclinical data for combination influenza and COVID-19 vaccine candidate
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from a preclinical study of the company's combination quadrivalent seasonal flu vaccine (NanoFlu™) and COVID-19 vaccine candidate (NVX-CoV2373). (Source: World Pharma News)
Source: World Pharma News - May 10, 2021 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 6, 2021 Category: American Health Tags: Anxiety Fainting (syncope) MMWR Morbidity & Mortality Weekly Report COVID-19 Coronavirus Disease 2019 Source Type: news
Why Men Are Falling Behind in COVID-19 Vaccination
In the United States, COVID-19 has been more likely to kill men than women: about 13 men have died of the disease for every 10 women, according to data collected by The Sex, Gender and Covid-19 Project at University College London. Fortunately, there’s one clear way to reduce the disparity: the three vaccines authorized for use in the U.S. have all been shown to reduce patients’ risk of dying of or being hospitalized with COVID-19 to nearly zero. However, many men in the U.S. aren’t racing to get vaccinated. As of May 3, about 38.5% of the male population has been vaccinated, compared to 43.3% of the fema...
Source: TIME: Health - May 4, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news
Anxiety-Related Adverse Event Clusters ID'd After Janssen Vaccine
MONDAY, May 3, 2021 -- Syncope and other anxiety-related events occur more often after receipt of Janssen COVID-19 vaccines than influenza vaccination, according to research published in the April 30 early-release issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2021 Category: Pharmaceuticals Source Type: news
Intranasal influenza vaccine enhances immune response and offers broad protection, researchers find
(Georgia State University) An influenza vaccine that is made of nanoparticles and administered through the nose enhances the body's immune response to influenza virus infection and offers broad protection against different viral strains, according to researchers in the Institute for Biomedical Sciences at Georgia State University. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 3, 2021 Category: Infectious Diseases Source Type: news
COVID-19 Pandemic Tied to Historically Low Influenza Cases, Leading to Uncertainty about Next Winter ’s Flu Vaccine
Clinical laboratories may see increase in flu and COVID-19 specimen processing as people return to pre-pandemic social behaviors, experts predict While SARS-CoV-2 infections continue to ravage many parts of the world, influenza (flu) cases in North America have hit a historic low. As winter approached last year, infectious disease experts warned of a “twindemic” in […] The post COVID-19 Pandemic Tied to Historically Low Influenza Cases, Leading to Uncertainty about Next Winter’s Flu Vaccine appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - April 30, 2021 Category: Laboratory Medicine Authors: Kristen Noonan Tags: Laboratory News Laboratory Operations Laboratory Pathology News From Dark Daily anatomic pathology Andrew Pekosz PhD CDC Center for Emerging Viruses and Infectious Diseases centers for disease control and prevention CEVID Children’s Source Type: news
Should Clinicians Be Required to Get COVID-19 Vaccines? Should Clinicians Be Required to Get COVID-19 Vaccines?
Some healthcare workers are required to get annual influenza vaccines. Should there be a similar mandate for COVID-19 vaccination?Medscape Reader Polls (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 28, 2021 Category: Emergency Medicine Tags: Family Medicine/Primary Care News Source Type: news
Coronavirus live news: India deaths pass 200,000; crisis needs global response – Fauci
India hits another global record;US expert says richer countries must do more to help fight crisis in IndiaWorld has failed India, says US expert Dr FauciFears of Covid ‘tsunami’ as India variant drives outbreakSingle vaccine dose found to nearly halve transmissionSpain to welcome overseas travellers with Covid certificates from JuneSee all our coronavirus coverage8.25amBSTThere ’s been some reaction in the UK media tothe Public Health England study that shows vaccines cutting transmission rates in England as well as preventing more serious infection symptoms.Dr Mike Tildesley, from the University of Warw...
Source: Guardian Unlimited Science - April 28, 2021 Category: Science Authors: Martin Belam (now) and Martin Farrer (earlier) Tags: Coronavirus India Science Infectious diseases US news Source Type: news
How the Human Life Span Doubled in 100 Years
Between 1920 and 2020, the average human life span doubled. How did we do it? Science mattered — but so did activism. (Source: NYT Health)
Source: NYT Health - April 27, 2021 Category: Consumer Health News Authors: Steven Johnson Tags: Coronavirus Risks and Safety Concerns Epidemics Smallpox Antibiotics Disease Rates Vaccination and Immunization Influenza Epidemic (1918-19) Longevity Population Milk Infant Mortality Statistics Cholera Food and Drug Administrati Source Type: news
Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participa...
Source: Johnson and Johnson - April 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Patients of Female Doctors More Likely to Receive Flu Vaccine
MONDAY, April 19, 2021 -- Medicare patients of female physicians are more likely than patients of male physicians in the same practice to receive the influenza vaccine, according to a research letter published online April 12 in JAMA Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2021 Category: Pharmaceuticals Source Type: news
Will You Need a Booster Shot of the COVID-19 Vaccine?
When the first COVID-19 vaccines from Pfizer-BioNTech and Moderna were authorized by the U.S. Food and Drug Administration in December 2020, most people breathed a sigh of relief since both shots were shown to be between 94% and 95% effective in protecting from COVID-19 symptoms. But public health experts warned that nobody really knew how long the protection would last, since the longest clinical trials in people only went to a few months. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and the chief medical advisor to President Joe Biden, suggested that additional booster ...
Source: TIME: Health - April 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Patients of women doctors more likely to be vaccinated against the flu
(University of California - Los Angeles Health Sciences) New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu. This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 15, 2021 Category: Infectious Diseases Source Type: news
Patients of women doctors more likely to be vaccinated against the flu
New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu.This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses,according to the research letter, which is published in the peer-reviewed JAMA Internal Medicine.Prior studies have shown that female physicianstend tospend more time with their patients, said study author Dr. Dan Ly, anassistant professor in the division of general internal medicine and...
Source: UCLA Newsroom: Health Sciences - April 14, 2021 Category: Universities & Medical Training Source Type: news
Coronavirus vaccine technology is paving the way for a whole new approach to flu shots
Messenger RNA influenza vaccines could be more effective than traditional flu shots and protect against numerous strains for years at time, researchers say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 11, 2021 Category: Consumer Health News Authors: Lindsey Bever Source Type: news
QuickStats: Age-Adjusted Percentage of Adults Aged ≥18 Years Who Had an Influenza Vaccination in the Past 12 Months, by Sex and Race/Ethnicity - National Health Interview Survey, United States, 2019
This report describes the age-adjusted percentage of adults who received an influenza vaccination in the U.S. in 2019. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 8, 2021 Category: American Health Tags: Adult Health Influenza (Flu) MMWR Morbidity & Mortality Weekly Report Race and Ethnicity Vaccination Source Type: news